Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Gregory Haft
Simvastatin/Fenofibrate Combination in the Treatment of Dyslipidemia: Current Evidence
Research and Reports in Endocrine Disorders
Related publications
Simvastatin Plus Fenofibrate as a Fixed Dose Combination in the Treatment of Mixed Dyslipidemia in Greece: Budget Impact Analysis
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Effect of Combination Therapy With Fenofibrate and Simvastatin on Postprandial Lipemia in the ACCORD Lipid Trial
Diabetes Care
Internal Medicine
Endocrinology
Advanced
Metabolism
Specialized Nursing
Diabetes
Management of Dyslipidemia and Hyperglycemia With a Fixed-Dose Combination of Sitagliptin and Simvastatin
Vascular Health and Risk Management
Chemokine, Vascular and Therapeutic Effects of Combination Simvastatin and BMSC Treatment of Stroke
Neurobiology of Disease
Neurology
Using a Combination of Perindopril, Indapamide and Rosuvastatin in the Treatment of Patients With Hypertension and Dyslipidemia
Rational Pharmacotherapy in Cardiology
Cardiovascular Medicine
Pharmacology
Cardiology
Drug Treatment of Hyperlipidemia in Chinese Patients: Focus on the Use of Simvastatin and Ezetimibe Alone and in Combination
American Journal of Cardiovascular Drugs
Medicine
Cardiovascular Medicine
Pharmacology
Cardiology
Evaluating the Cost-Utility of Fenofibrate Treatment of Diabetic Retinopathy in Australia
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
PCSK9 Inhibition: The Way Forward in the Treatment of Dyslipidemia
BMC Medicine
Medicine
Teriflunomide in the Treatment of Multiple Sclerosis: Current Evidence and Future Prospects
Therapeutic Advances in Neurological Disorders
Neurology
Pharmacology